Friday 6 November 2026
Export AZTA’s income statement to Excel — free account
Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024.
- Revenue
- +12.0%
- EPS
- +104.4%
- Free cash flow
- −134.7%
Quarter to June 2026, against a year earlier
39.23
1.85
+4.95%
Follow AZTA
Alert me
Azenta, Inc. (AZTA) P/E ratio
Azenta, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 107× (July 2015) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 1.5× | (97.80%) |
| FY2021 | 68.7× | 30.67% |
| FY2020 | 52.6× | 760.28% |
| FY2019 | 6.1× | (70.75%) |
| FY2018 | 20.9× | (39.78%) |
| FY2017 | 34.7× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 107×
Ten-year median
6.5×
Current reading's percentile
39
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| STAA STAAR Surgical Company compare | n/m |
| AZTA Azenta, Inc. | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| STVN Stevanato Group S.p.A. compare | 22.4× |
| LMAT LeMaitre Vascular, Inc. compare | 29.7× |
| ATRC AtriCure, Inc. compare | 199× |
| WRBY Warby Parker Inc. compare | 434× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)